Recruiting NA Gestational Diabetes

New treatment option for Gestational Diabetes

Official title Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)

ClinicalTrials.gov ID: NCT05081037

What this study is testing

What it's testing
This study aims to test the following hypotheses in a randomized controlled trial of post-partum women with a history of gestational diabetes mellitus (GDM) that will be followed up for up to 4 years: 1. Post-partum pregnancy is ideal for behavioural modification and adopting a healthy lifestyle.
  • Time commitment: about 4 years
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 45, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Women diagnosed antenatally with GDM by IADPSG criteria (15)
  • Normal 6 weeks post-natal OGTT
  • BMI range from 20-40
  • Physically fit to participate in moderate intensity walking

You likely can't join if

  • Women with serious skin conditions (e.g. eczema) that precludes wearing the sensor for 14 days
  • Women who have any other serious chronic disease such as chronic kidney disease and heart disease

The study team makes the final eligibility decision.

Where it's taking place

  • Singapore, Singapore

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 4 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling female, 21 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.